Login

Iterum Therapeutics Relocates U.S. Headquarters to 200 S. Wacker

Newmark Knight Frank Facilitates Deal for Pharmaceutical Company
By Carlos Pietri
August 17, 2018 | 1:00 P.M.

The U.S. subsidiary of clinical-stage pharmaceutical company Iterum Therapeutics plc has relocated its U.S. headquarters from 200 W. Monroe St. to the nearby 200 S. Wacker building in Chicago's West Loop.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE